immatics biotechnologies GmbH Cash Flow Reinvestment Rate

Latest as of December 2023: 0.87x

immatics biotechnologies GmbH cash flow reinvestment rate. immatics biotechnologies GmbH (4A3) has a Cash Flow Reinvestment Rate of 0.87x as of December 2023, reinvesting €69.03 Million (capex €9.29 Million plus investments €59.74 Million) from operating cash flow of €79.08 Million. Explore immatics biotechnologies GmbH debt service capacity to assess how comfortably operating cash covers total debt obligations.

Reinvestment Rate

0.87x
(Capex + Investments) / Operating CF

Total Reinvested

€69.03 Million
Capex + Investments

Operating Cash Flow

€79.08 Million
EUR

Capital Expenditures

€9.29 Million
EUR

Cash Flow Reinvestment Rate of immatics biotechnologies GmbH (2018–2023)

Cash flow reinvestment rate of immatics biotechnologies GmbH from 2018 to 2023. Historical reinvestment intensity for immatics biotechnologies GmbH across 6 annual periods. Explore how much does immatics biotechnologies GmbH reinvest in capital to see what proportion of operating cash flow is directed to capital expenditures.

immatics biotechnologies GmbH Cash Flow Reinvestment Rate by Year (2018–2023)

immatics biotechnologies GmbH cash flow reinvestment rate by year from 2018 to 2023. Year-by-year capital reinvestment analysis for immatics biotechnologies GmbH. For the full cash flow conversion analysis, see immatics biotechnologies GmbH (4A3) cash flow conversion.

Year Reinvestment Rate Total Reinvested (EUR) Operating CF Capex YoY Change
2023 3.42x €62.34 Million €18.23 Million €30.96 Million ▲ +63.6%
2022 2.09x €209.37 Million €100.13 Million €5.74 Million ▲ +1046.8%
2021 0.18x €18.26 Million €100.13 Million €5.11 Million ▲ +15.2%
2020 0.16x €15.85 Million €100.13 Million €7.42 Million ▲ +121.7%
2019 0.07x €5.07 Million €70.97 Million €2.14 Million ▼ -89.1%
2018 0.65x €13.53 Million €20.68 Million €429.00K —
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow